相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-cancer effect of GV1001 for prostate cancer: function as a ligand of GnRHR
Ji Won Kim et al.
ENDOCRINE-RELATED CANCER (2019)
Gonadotropin-releasing hormone signaling: An information theoretic approach
Margaritis Voliotis et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis
W-Y Chen et al.
ONCOGENE (2017)
Shift of EMT gradient in 3D spheroid MSCs for activation of mesenchymal niche function
Sohee Jeon et al.
SCIENTIFIC REPORTS (2017)
Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling
Ihsan Y. El-Sayed et al.
CANCER LETTERS (2017)
The roles of the Hippo pathway in cancer metastasis
Helena J. Janse van Rensburg et al.
CELLULAR SIGNALLING (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
YAP promotes erlotinib resistance in human non-small cell lung cancer cells
Ping-Chih Hsu et al.
ONCOTARGET (2016)
Targetable YAP1–AR interaction key to disease progression
Clemens Thoma
Nature Reviews Urology (2015)
YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer
Gamze Kuser-Abali et al.
NATURE COMMUNICATIONS (2015)
The Hippo signaling pathway in stem cell biology and cancer
Jung-Soon Mo et al.
EMBO REPORTS (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
Kouji Izumi et al.
EMBO MOLECULAR MEDICINE (2013)
Interactions of the GnRH receptor with heterotrimeric G proteins
Zvi Naor et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2013)
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
Ayesha A. Shafi et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Activation of Estrogen Receptor by Bavachin from Psoralea corylifolia
Joonwoo Park et al.
BIOMOLECULES & THERAPEUTICS (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival
Peck Yean Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Cancer vaccination with telomerase peptide GV1001
Jon Amund Kyte
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Type I Gonadotropin-Releasing Hormone Receptor Mediates the Antiproliferative Effects of GnRH-II on Prostate Cancer Cells
Marina Montagnani Marelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2
Siting Feng et al.
MOLECULAR CANCER THERAPEUTICS (2009)
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Xi Wang et al.
NATURE (2009)
Loss of NKX3.1 Favors Vascular Endothelial Growth Factor-C Expression in Prostate Cancer
Heyu Zhang et al.
CANCER RESEARCH (2008)
Antiproliferative effects of GnRH agonists: Prospects and problems for cancer therapy
Colin D. White et al.
NEUROENDOCRINOLOGY (2008)
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
Hannelore V. Heemers et al.
ENDOCRINE REVIEWS (2007)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss
Qunying Lei et al.
CANCER CELL (2006)
Gonadotropin-releasing hormone in apoptosis of prostate cancer cells
S Kraus et al.
CANCER LETTERS (2006)
STRING: known and predicted protein-protein associations, integrated and transferred across organisms
C von Mering et al.
NUCLEIC ACIDS RESEARCH (2005)
Gonadotropin-releasing hormone receptors
RP Millar et al.
ENDOCRINE REVIEWS (2004)
Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells:: Role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways
S Kraus et al.
CANCER RESEARCH (2004)
Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Gαi-coupling state of the type I GnRH receptor
S Maudsley et al.
CANCER RESEARCH (2004)
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts
S Wu et al.
CELL (2003)
Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer
SK Kang et al.
ENDOCRINE-RELATED CANCER (2003)
An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion
LZ Krsmanovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Low expression of Ga protein subunits in human prostate cancer
MO García-Fernández et al.
JOURNAL OF UROLOGY (2001)
Effects of the luteinising hormone-releasing hormone (LH-RH) agonist leuprolide on adenylyl cyclase regulation through G-protein coupled receptors in rat ventral prostate
A Salvador et al.
EUROPEAN JOURNAL OF CANCER (2001)
Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to Gq/11 proteins
R Grosse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
